These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 20166933)
21. Survivin as a Potential Target for Cancer Therapy. Soleimanpour E; Babaei E Asian Pac J Cancer Prev; 2015; 16(15):6187-91. PubMed ID: 26434815 [TBL] [Abstract][Full Text] [Related]
22. [Research advances on inhibitor of apoptosis, survivin]. Yang J; Liu FX; Yan XC Ai Zheng; 2003 Jul; 22(7):771-4. PubMed ID: 12866973 [TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus LMP1 initiates cell proliferation and apoptosis inhibition via regulating expression of Survivin in nasopharyngeal carcinoma. Faqing T; Zhi H; Liqun Y; Min T; Huanhua G; Xiyun D; Ya C Exp Oncol; 2005 Jun; 27(2):96-101. PubMed ID: 15995625 [TBL] [Abstract][Full Text] [Related]
24. Survivin is not only a death encounter but also a survival protein for invading tumor cells. Ouhtit A; Matrougui K; Bengrine A; Koochekpour S; Zerfaoui M; Yousief Z Front Biosci; 2007 Jan; 12():1260-70. PubMed ID: 17127378 [TBL] [Abstract][Full Text] [Related]
25. Survivin and apoptosis control. Altieri DC Adv Cancer Res; 2003; 88():31-52. PubMed ID: 12665052 [TBL] [Abstract][Full Text] [Related]
26. Survivin study: what is the next wave? Li F J Cell Physiol; 2003 Oct; 197(1):8-29. PubMed ID: 12942537 [TBL] [Abstract][Full Text] [Related]
28. Survivin: a new target for anti-cancer therapy. Ryan BM; O'Donovan N; Duffy MJ Cancer Treat Rev; 2009 Nov; 35(7):553-62. PubMed ID: 19559538 [TBL] [Abstract][Full Text] [Related]
29. The role of survivin as a new target of diagnosis and treatment in human cancer. Yamamoto T; Tanigawa N Med Electron Microsc; 2001 Dec; 34(4):207-12. PubMed ID: 11956993 [TBL] [Abstract][Full Text] [Related]
30. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells. Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic strategies involving survivin inhibition in cancer. Martínez-García D; Manero-Rupérez N; Quesada R; Korrodi-Gregório L; Soto-Cerrato V Med Res Rev; 2019 May; 39(3):887-909. PubMed ID: 30421440 [TBL] [Abstract][Full Text] [Related]
32. Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin. Kelly RJ; Lopez-Chavez A; Citrin D; Janik JE; Morris JC Mol Cancer; 2011 Apr; 10():35. PubMed ID: 21470426 [TBL] [Abstract][Full Text] [Related]
33. Discovery of a novel small molecule binding site of human survivin. Wendt MD; Sun C; Kunzer A; Sauer D; Sarris K; Hoff E; Yu L; Nettesheim DG; Chen J; Jin S; Comess KM; Fan Y; Anderson SN; Isaac B; Olejniczak ET; Hajduk PJ; Rosenberg SH; Elmore SW Bioorg Med Chem Lett; 2007 Jun; 17(11):3122-9. PubMed ID: 17391963 [TBL] [Abstract][Full Text] [Related]
34. Coexpression of survivin and PCNA in pituitary tumors and normal pituitary. Wasko R; Waligorska-Stachura J; Jankowska A; Warchol JB; Liebert W; Sowinski J Neuro Endocrinol Lett; 2009; 30(4):477-81. PubMed ID: 20010504 [TBL] [Abstract][Full Text] [Related]
35. Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential. Khan S; Aspe JR; Asumen MG; Almaguel F; Odumosu O; Acevedo-Martinez S; De Leon M; Langridge WH; Wall NR Br J Cancer; 2009 Apr; 100(7):1073-86. PubMed ID: 19293795 [TBL] [Abstract][Full Text] [Related]
36. Survivin expression in juvenile-onset recurrent respiratory papillomatosis. Poetker DM; Sandler AD; Scott DL; Smith RJ; Bauman NM Ann Otol Rhinol Laryngol; 2002 Nov; 111(11):957-61. PubMed ID: 12450166 [TBL] [Abstract][Full Text] [Related]
37. Nuclear export is essential for the tumor-promoting activity of survivin. Knauer SK; Krämer OH; Knösel T; Engels K; Rödel F; Kovács AF; Dietmaier W; Klein-Hitpass L; Habtemichael N; Schweitzer A; Brieger J; Rödel C; Mann W; Petersen I; Heinzel T; Stauber RH FASEB J; 2007 Jan; 21(1):207-16. PubMed ID: 17099069 [TBL] [Abstract][Full Text] [Related]
38. Cloning and functional characterization of the guinea pig apoptosis inhibitor protein Survivin. Habtemichael N; Wünsch D; Bier C; Tillmann S; Unruhe B; Frauenknecht K; Heinrich UR; Mann WJ; Stauber RH; Knauer SK Gene; 2010 Dec; 469(1-2):9-17. PubMed ID: 20727954 [TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor-I receptor signaling pathway induces resistance to the apoptotic activities of SCH66336 (lonafarnib) through Akt/mammalian target of rapamycin-mediated increases in survivin expression. Oh SH; Jin Q; Kim ES; Khuri FR; Lee HY Clin Cancer Res; 2008 Mar; 14(5):1581-9. PubMed ID: 18316583 [TBL] [Abstract][Full Text] [Related]
40. Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma. Takai N; Miyazaki T; Nishida M; Nasu K; Miyakawa I Cancer Lett; 2002 Oct; 184(1):105-16. PubMed ID: 12104054 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]